Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Charles R Joseph

6PUBLICATIONS
5CO-AUTHORS
Molecular imaging (incl. electron microscopy and neutron diffraction)MechanobiologyNeurology and neuromuscular diseasesProsthetics and orthoticsSpatial data and applications
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Jun 13, 2025
Dementia from Small Vessel Disease Versus Alzheimer's Disease: Separate Diseases or Distinct Manifestations of Cerebral Capillopathy Due to Blood-Brain Barrier Dysfunction? A Pilot Study.

Charles R Joseph, Davis A Melin, Lindsay K Wanner

|Nov 09, 2024
Assessing Mild Traumatic Brain Injury-Associated Blood-Brain Barrier (BBB) Damage and Restoration Using Late-Phase Perfusion Analysis by 3D ASL MRI: Implications for Predicting Progressive Brain Injury in a Focused Review.

Charles R Joseph

|Apr 13, 2024
Progressive Age-Associated Blood-Brain Barrier Leak/Dysfunction-Nexus of Neurodegenerative Disease Using MRI Markers to Identify Preclinical Disease and Potential New Targets for Future Treatments.

Charles R Joseph

|Sep 26, 2022
Integrated Osteopathic-Neurologic Examinations With Musculoskeletal Treatment: The ONE Approach.

Charles R Joseph, Michael D Lockwood, Michael P Cargill

|Aug 10, 2022
Utilizing timed categorical recall (naming US cities) for rapid bedside dementia screening.

Charles R Joseph, Michael P Cargill, Chansoon D Lee

|Jan 04, 2020
Pilot study utilizing MRI 3D TGSE PASL (arterial spin labeling) differentiating clearance rates of labeled protons in the CNS of patients with early Alzheimer disease from normal subjects.

Charles R Joseph, Christopher M Benhatzel, Logan J Stern

Pageof 1

Frequent Collaborators

1 joint publications

Davis A Melin

1 joint publications

Lindsay K Wanner

1 joint publications

Bryant Hartman

1 joint publications

Lucy C Conser

1 joint publications

Kim Love

Frequent Collaborators

1 joint publications

Davis A Melin

1 joint publications

Lindsay K Wanner

1 joint publications

Bryant Hartman

1 joint publications

Lucy C Conser

Top Related Videos

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction
04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

Published on : May 17, 2024

578
Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury
05:19

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury

Published on : Oct 18, 2024

559
Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
07:22

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease

Published on : Nov 08, 2017

10.0K
See more related videos

Top Related Videos

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction
04:29

A Visual Approach for Inducing Dolichoectasia in Mice to Model Large Vessel-Mediated Cerebrovascular Dysfunction

Published on : May 17, 2024

578
Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury
05:19

Evaluation of Blood-Brain Barrier Breakdown in a Mouse Model of Mild Traumatic Brain Injury

Published on : Oct 18, 2024

559
Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease
07:22

Assessment of Blood-brain Barrier Permeability by Intravenous Infusion of FITC-labeled Albumin in a Mouse Model of Neurodegenerative Disease

Published on : Nov 08, 2017

10.0K
See more related videos